Microglia affect α-synuclein cell-to-cell transfer in a mouse model of Parkinson’s disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1750-1326
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Microglia affect α-synuclein cell-to-cell transfer in a mouse model of Parkinson’s disease ; volume:14 ; number:1 ; day:16 ; month:8 ; year:2019 ; pages:1-22 ; date:12.2019
Molecular neurodegeneration ; 14, Heft 1 (16.8.2019), 1-22, 12.2019
- Urheber
-
George, Sonia
Rey, Nolwen L.
Tyson, Trevor
Esquibel, Corinne
Meyerdirk, Lindsay
Schulz, Emily
Pierce, Steven
Burmeister, Amanda R.
Madaj, Zachary
Steiner, Jennifer A.
Escobar Galvis, Martha L.
Brundin, Lena
Brundin, Patrik
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13024-019-0335-3
- URN
-
urn:nbn:de:101:1-2020010202510422505501
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
13.02.2028, 00:01 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- George, Sonia
- Rey, Nolwen L.
- Tyson, Trevor
- Esquibel, Corinne
- Meyerdirk, Lindsay
- Schulz, Emily
- Pierce, Steven
- Burmeister, Amanda R.
- Madaj, Zachary
- Steiner, Jennifer A.
- Escobar Galvis, Martha L.
- Brundin, Lena
- Brundin, Patrik
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cell-to-cell transmitted alpha-synuclein recapitulates experimental Parkinson’s disease
Curcumin reduces α-synuclein induced cytotoxicity in Parkinson's disease cell model
Models of α-synuclein aggregation in Parkinson’s disease
Immune responses to oligomeric α-synuclein in Parkinson’s disease peripheral blood mononuclear cells
LRRK2 interactions with α-synuclein in Parkinson’s disease brains and in cell models
Dermal α-synuclein oligomers and aggregates in Parkinson’s disease
Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
Initiation and progression of α-synuclein pathology in Parkinson’s disease
GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson’s Disease
Phosphorylated α-synuclein deposited in Schwann cells interacting with TLR2 mediates cell damage and induces Parkinson’s disease autonomic dysfunction
Adenosine A1 receptor ligands bind to α-synuclein: implications for α-synuclein misfolding and α-synucleinopathy in Parkinson’s disease
Cell-to-cell transmitted alpha-synuclein recapitulates experimental Parkinson’s disease
Curcumin reduces α-synuclein induced cytotoxicity in Parkinson's disease cell model
Models of α-synuclein aggregation in Parkinson’s disease
Immune responses to oligomeric α-synuclein in Parkinson’s disease peripheral blood mononuclear cells
LRRK2 interactions with α-synuclein in Parkinson’s disease brains and in cell models
Dermal α-synuclein oligomers and aggregates in Parkinson’s disease
Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
Initiation and progression of α-synuclein pathology in Parkinson’s disease
GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson’s Disease
Phosphorylated α-synuclein deposited in Schwann cells interacting with TLR2 mediates cell damage and induces Parkinson’s disease autonomic dysfunction
Adenosine A1 receptor ligands bind to α-synuclein: implications for α-synuclein misfolding and α-synucleinopathy in Parkinson’s disease
Cell-to-cell transmitted alpha-synuclein recapitulates experimental Parkinson’s disease
Curcumin reduces α-synuclein induced cytotoxicity in Parkinson's disease cell model
Models of α-synuclein aggregation in Parkinson’s disease
Immune responses to oligomeric α-synuclein in Parkinson’s disease peripheral blood mononuclear cells
LRRK2 interactions with α-synuclein in Parkinson’s disease brains and in cell models
Dermal α-synuclein oligomers and aggregates in Parkinson’s disease
Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
Initiation and progression of α-synuclein pathology in Parkinson’s disease
GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson’s Disease
Phosphorylated α-synuclein deposited in Schwann cells interacting with TLR2 mediates cell damage and induces Parkinson’s disease autonomic dysfunction